Source of material (Bu4N)2[Zn(dmit)2] was dissolved in acetonitrile and 3-bromopropionitrile was added to the solution and was refluxed for 2 h. The solution was filtered off. After adding chloroform, the solution was washed with aqueous sodium hydrogencarbonate, and then with water. After drying over Na2SC>4, the drying agent was removed. The methanol was added to the solution. The solution was evaporated, and yellow needle-like crystals of the title compound were obtained [1] .
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Discussion
The title compound is a precursor for preparation of TTF (tetrathiafulvalene) derivatives or their charge-transfer salts, which are of interest for their high electronic conductivity or superconductivity [2] . X-ray diffraction studies have been undertaken, as the structure has not previously been reported in the literature. The crystal structure exhibits two independent conformers in the asymmetric unit (labeled by suffix A and Β in the figure). Each of them can be described as having a syn orientation of the two cyanoethyl substituents with respect to the rough plane of dmit(4,5-dimercapto-l,3-dithiole-2-thione) moiety. The conformational changes for both conformers involve rotations around 
